D
ynamic regulation of the actin cytoskeleton is required for the formation and dissolution of intercellular adhesions during tissue morphogenesis (1) and pathological processes such as tumor invasion and metastasis (2, 3) . The formation of cell-cell contacts is dependent on the assembly of adherens junctions (1) , which are specialized structures that link transmembrane cadherins in neighboring cells to the actin cytoskeleton (1) . The extracellular domain of the cadherins cluster in a calcium-dependent manner and trigger association of the cadherin cytoplasmic domain with ␤-catenin, which in turn binds to ␣-catenin, a protein that links the cadherincatenin complex to the actin cytoskeleton (1) . Disruption of the actin cytoskeleton, genetic inactivation of actin regulatory proteins, or disruption of the link between the cadherin-catenin complex and the actin cytoskeleton all result in a loss of adherens junctions (4) (5) (6) . Adherens junction formation, stability, and dissolution are processes regulated by Rho family GTPases (7) . However, little is known about the mechanisms that link cadherin-mediated signaling to regulation of Rho GTPases, leading to dynamic reorganization of the actin cytoskeleton.
Abl (Abl1) and Arg (Abl2) define a family of nonreceptor tyrosine kinases characterized by unique carboxy-terminal, actinbinding domains that can bundle actin (8) . The Abl kinases regulate a variety of cytoskeletal processes downstream of receptor tyrosine kinases and integrins (9) (10) (11) (12) (13) (14) . We have shown that Abl kinases play a role in the regulation of intercellular signals at the neuromuscular junction (NMJ) and at sites of contact between invading bacterial pathogens and mammalian host cells (9, 15) . Genetic studies in Drosophila and mice support a role for Abl kinases in the regulation of epithelial morphogenesis (16) (17) (18) . Mice lacking Abl and Arg die before embryonic day 11 and display collapse of the neural tube, which is secondary to the disruption of the apical actin latticework in neuroepithelial cells (18) . Based on the unique properties of the Abl kinases, we asked whether Abl and Arg regulate the formation and/or maintenance of adherens junctions in mammalian cells and sought to define a pathway whereby the Abl kinases modulate these processes. Here we identify a role for Abl kinases in the regulation of cell-cell adhesion through modulation of Rho family GTPases.
Results
Abl Kinases Are Required for Cell-Cell Adhesion. To determine whether the Abl kinases are involved in the regulation of cadherinmediated cell-cell adhesion, we first examined the consequences of genetic inactivation of Abl and Arg on the formation of N-cadherindependent cell-cell junctions in mouse embryo fibroblasts (MEFs) (19) . Abl Ϫ/Ϫ Arg Ϫ/Ϫ MEFs were reengineered to reexpress Abl and Arg (13, 15) . Cells expressing Abl and Arg displayed continuous cell-cell junctions similar to wild-type (WT) MEFs as visualized by staining for N-cadherin, ␤-catenin, and ␣-catenin (Fig. 1A Upper) . In contrast, adherens junction proteins failed to accumulate at sites of cell-cell contact in Abl Ϫ/Ϫ Arg Ϫ/Ϫ MEFs ( Fig. 1 A Lower) . Loss of Abl and Arg did not alter the expression levels of adherens junction proteins (Fig. 1B) . To assess the role of Abl kinases in the formation of adherens junctions, cell monolayers were placed in low-calcium media to dissolve preexisting cell-cell junctions, and then were switched to high-calcium media to activate cadherinmediated intercellular adhesion. Notably, Ͼ90% of cells expressing Abl/Arg formed adherens junctions after 4 h in high-calcium media (Fig. 1C Upper) . In contrast, Abl Ϫ/Ϫ Arg Ϫ/Ϫ cells displayed a disorganized N-cadherin-staining pattern and were unable to form discrete adherens junctions even 4 h after addition of high-calcium medium (Fig. 1C Lower) . These data reveal that Abl kinases are required for the formation of adherens junctions in fibroblasts.
We next examined whether Abl kinase activity plays a role in the regulation of epithelial cell-cell junctions. Confluent NBT-II rat epithelial cells were stimulated to form adherens junctions by calcium switch in the presence or absence of STI571, a pharmacological inhibitor of the Abl kinases (20, 21) . In control cells, ␤-catenin accumulated at sites of cell-cell contact after incubation in high-calcium media ( Fig. 2A Upper) . In contrast, cells treated with the Abl kinase inhibitor failed to induce ␤-catenin-containing protrusions and to form adherens junctions ( Fig. 2 A Lower) . Abl kinases were markedly inhibited by 10 M STI571 as determined by the reduction of endogenous CrkL phosphorylation on Y207, the Abl-specific site (Fig. 2B ). To determine whether Abl/Arg proteins are required for intercellular adhesion in E-cadherin-expressing epithelial cells, Abl/Arg expression was down-regulated by using RNAi (Fig. 2C) . NBT-II cells transfected with Abl, Arg, or both Abl-and Arg-directed siRNAs showed decreased levels of ␤-catenin containing cell-cell junctions. To determine whether this effect is observed in other E-cadherin-expressing epithelial cells, Abl/Arg expression was down-regulated by RNAi in MCF-10A cells [ Fig. 2D and supporting information (SI) Fig. 8C ]. MCF-10A cells transfected with Abl-and Arg-directed siRNAs showed decreased levels of E-cadherin and catenins at sites of cell-cell contact or lacked cell-cell contacts completely with no change in adherens junction protein expression ( Fig. 2D and SI Fig. 8 ). These data support a critical role for Abl family protein and kinase activity in the formation of epithelial adherens junctions.
Abl Kinases Are Required for the Maintenance of Adherens Junctions.
Adherens junctions are dynamic structures that undergo constant remodeling (22) . To test the involvement of Abl kinases in adherens junction stability, Abl activity was inhibited with STI571 after formation of confluent monolayers of NBT-II epithelial cells. Treatment with STI571 for 3 h resulted in the relocalization of ␤-catenin from adherens junctions to the cytoplasm (Fig. 3A) . After 6 h of STI571 treatment, only 40% of the cells retained adherens junctions (Fig. 3 A and B) . Adherens junction protein expression was unaffected by Abl kinase inhibition for Յ6 h (Fig. 3C) . Similarly, STI571 treatment of MCF-10A cells promoted mislocalization of adherens junction proteins ( Fig. 3D ) with no change in E-cadherin and ␣-catenin protein levels (Fig. 3E) or the integrity of the E-cadherin-␣-catenin complex (Fig. 3F) . Moreover, we did not observe any changes in the tyrosine phosphorylation of the cadherin-catenin complex in the absence of Abl kinases or after inhibition of Abl kinase activity (data not shown).
Cell-Cell Adhesion Leads to Abl Kinase Activation and Recruitment to
Sites of Cell-Cell Contact. To test whether Abl kinases are catalytically activated by cell-cell adhesion, we analyzed the phosphorylation of the Abl substrates CrkII or the related CrkL by using phosphospecific antibodies against the Abl-specific sites, which have been shown to be unphosphorylated in Abl Ϫ/Ϫ Arg Ϫ/Ϫ MEFs or in cells lacking Abl kinase activity (15, 23) . Abl kinase activity was up-regulated by 5 min after calcium switch to induce cadherinmediated cell-cell adhesion, and Abl activation was sustained for 30 min in WT MEFs (Fig. 4A) . Similar kinetics were observed in NBT-II cells by using in vitro kinase assays with GST-Crk to measure Abl/Arg kinase activity (Fig. 4B) (24) . To eliminate the possible contribution of intercellular adhesion-independent effects, we compared Abl activation in sparse versus confluent cultures and found that Abl kinase activity is unaltered in the absence or presence of calcium in sparse cultures (Fig. 4 C and D) . In contrast, Abl kinase activity increases in a time-dependent manner after calcium switch in confluent cell monolayers ( Fig. 4 C and D) . Thus, regulation of Abl kinase activity after calcium switch is dependent on cadherin-mediated cell-cell contacts.
To determine whether Abl and Arg are recruited to sites of cell-cell contact to participate in signaling, we generated MadinDarby Canine Kidney (MDCK) cell lines expressing GFP-tagged versions of the Abl kinases and examined the localization of these kinases during adherens junction formation. Arg accumulated at sites of cell-cell contact and in the cytoplasm in both confluent cells, and in cells stimulated to reform adherens junctions by switch to high-calcium medium (SI Fig. 9A ). Similar results were observed for GFP-Abl (data not shown). In confluent MCF-10A cells, Arg also colocalized with ␤-catenin at sites of cell-cell contact (SI Fig.  9C) , and E-cadherin and ␤-catenin coimmunoprecipitated with GFP-Arg (SI Fig. 9B ). Disruption of cadherin-mediated cell-cell adhesion (low calcium) resulted in redistribution of Arg from adherens junctions to the cytoplasm (SI Fig. 9 A and C). After calcium switch, GFP-Arg relocalized in lamellipodial extensions and at sites of nascent cell-cell contacts (SI Fig. 9C ). These data further support a role for Abl and Arg in adherens junction regulation because both proteins are recruited to sites of cell-cell contact, are associated with E-cadherin-␤-catenin complexes, and are activated in response to cadherin engagement. Because formation of cell-cell junctions correlates with increased phosphorylation of Crk/CrkL proteins at the Abl-specific sites, we next examined whether Crk family proteins play a role in ArgPP-induced adherens junction strengthening by analyzing the consequences of Crk/CrkL siRNA-mediated knockdown. We observed a marked reduction in the integrity of adherens junctions in ArgPP-expressing cells transfected with Crk/CrkL siRNAs (SI Fig.   10 B and C). Similarly, junction integrity was markedly impaired in NBT-II cells transfected with Crk/CrkL siRNAs (SI Fig. 10D ). These data reveal a critical role for the Abl kinases in adherens junction formation in mammalian cells and suggest that this effect may be mediated, in part, by Crk proteins.
Abl Kinases Regulate Rac Activation in Response to
The Rac GTPase has been implicated in the formation of adherens junctions (26, 27) . In agreement with previous findings (27) , we observed that Rac was activated by 5 min of cadherin engagement (Fig. 5A ). Basal levels of activated Rac were unchanged in confluent monolayers of WT or Abl Ϫ/Ϫ Arg Ϫ/Ϫ MEFs grown in calcium-rich media (data not shown). Significantly, Rac activation induced by adherens junction formation was delayed and markedly reduced in Abl Ϫ/Ϫ Arg Ϫ/Ϫ cells ( Fig. 5 A and B) and in WT MEFs subjected to calcium switch in the presence of the Abl kinase inhibitor STI571 (Fig. 5C ). Previous studies have linked tyrosine phosphorylation of Crk to Rac activation after bacterial infection and integrin engagement (15, 28) . We found that overexpression of a Crk mutant lacking the Abl-specific phosphorylation site in MEFs decreased Rac activation during adherens junction formation (Fig.  5 D and E) . The inhibitory effect of the Crk mutant was similar to that induced by Abl kinase inhibition. These data suggest that Abl-mediated phosphorylation of Crk is required for maximal activation of Rac downstream of cadherin engagement.
Abl Kinases Regulate the Architecture of the Actin Cytoskeleton in
Epithelial Cell Sheets by the Rho-ROCK Pathway. The Abl kinases regulate multiple cytoskeletal processes such as membrane ruffling, chemotaxis, and cell spreading (29) . Dynamic regulation of the actin cytoskeleton is required for the formation, stability, and dissolution of adherens junctions (5, 6, 29, 30 ). Therefore, we tested whether Abl/Arg kinase inhibition could alter the cytoskeletal architecture of confluent cells. Epithelial cell clusters display thick cortical bundles of actin at cell-cell borders (Fig. 6A) . In contrast, cells treated with the Abl kinase inhibitor showed decreased cortical actin, increased stress fiber formation (accompanied by the appearance of gaps between cells), and increased numbers of spiky membrane protrusions (Fig. 6A) . The enhanced formation of stress fibers in STI571-treated cells suggested that inhibition of Abl kinases may result in increased Rho activity. Indeed, cellular levels of Rho-GTP increased after STI571 treatment, which correlated with the appearance of stress fibers (Fig. 6 A-C) . To determine whether loss of Abl/Arg proteins could similarly affect cadherinmediated regulation of Rho activity, we examined Rho activation in epithelial cells where Abl/Arg proteins were knocked down by RNAi. In agreement with previous findings (27) , cadherin engagement suppressed Rho activity in control epithelial cells (Fig. 6 E and  F) . In contrast, Rho inhibition after cadherin engagement was not observed in the Abl/Arg siRNA-treated confluent monolayers (Fig.  6 E and F) . Thus, the Abl kinases are required for cadherindependent inhibition of Rho activity. Rho activation may result in increased actomyosin contractility mediated through phosphorylation of the myosin regulatory light chain (MLC) of myosin II by Rho-activated kinases (31) . Inhibition of Abl family kinases resulted in a time-dependent increase of MLC phosphorylation and enhanced accumulation of phospho-MLC at the cell periphery, which correlated with increased formation of stress fibers (Fig. 6D) . Similarly, Abl kinase inhibition resulted in enhanced phosphorylation of MLC as assessed by immunoblotting to detect phosphoserine 19 of MLC (data not shown) (32) .
Rho signaling has been shown to regulate both the formation and dissolution of adherens junctions, and activation of the Rho effector ROCK has been shown to disrupt adherens junctions in epithelial cells (2, 3, 30, (33) (34) (35) (36) . To test whether the observed effects of Abl/Arg kinase inhibition are dependent on ROCK kinase activity, we examined whether the phenotypes induced by loss of Abl kinase activity could be reversed by inhibition of ROCK. Consistent with previous findings (3), cells treated with the ROCK kinase inhibitor Y27632 for 1 h did not display adherens junctions defects, but did show a marked decrease of stress fibers at the cell center (Fig. 7A) . Significantly, cells treated with both STI571 and Y27632 failed to display any of the aberrant morphology characteristic of STI571-treated cells, with ␤-catenin and actin remaining localized to sites of cell-cell contacts. Also, stress fiber formation was inhibited in these cells (Fig. 7 A-C) . Notably, whereas inhibition of the Abl kinases resulted in a 60% decrease in the percentage of cells with mature, continuous adherens junctions, this effect was blocked by the inhibition of ROCK (Fig. 7C) . Further, dual inhibition of both Abl and ROCK kinases abolished the increase in pMLC and the enhanced localization of MLC protein to the cell membrane (data not shown). Thus, inhibition of Abl kinase activity leads to upregulation of Rho-ROCK signaling, enhanced MLC phosphorylation, and increased actomyosin contractility, thereby promoting the dissolution of cell-cell adhesions. Together these data support a model whereby endogenous Abl kinases normally function to modulate Rho-ROCK activity and maintain cell-cell contacts in epithelial cell sheets (SI Fig. 11 ).
Discussion
Here we identify the Abl family of tyrosine kinases as critical mediators of cadherin-dependent adhesion in mammalian cells through regulation of Rho family GTPases. We have used genetic ablation and pharmacological inhibition to show that Abl kinases are required for the formation of adherens junctions and that loss of Abl kinases impairs Rac activation induced by cadherin engagement. Additionally, we show that Abl gain of function promotes adherens junction formation in cells with weak junctions and that Crk/CrkL proteins are required for this strengthening phenotype.
Significantly, we show that Abl kinases are activated by cadherin engagement, are recruited to nascent junctions, and are present in E-cadherin-␤-catenin complexes. Additionally, we have shown that Abl kinase activity is required for the maintenance of adherens junctions in epithelial cell sheets because inhibition of these kinases results in the redistribution of adherens junction components from sites of cell-cell contact to the cytoplasm. Abl kinases are required for maximal Rac activation induced by cadherin-mediated adhesion, and modulate cell-cell adhesion through other pathways. Inhibition of the Abl kinases in epithelial sheets results in activation of Rho and its downstream target ROCK, leading to enhanced phosphorylation of the MLC. Activation of this signaling pathway leads to enhanced stress fiber formation and increased actomyosin contractility, thereby disrupting adherens junctions. These findings identify a role for the Abl kinases as regulators of intercellular adhesion through their ability to modulate both Rac and Rho.
Notably, we showed that Abl kinases activated by cadherin engagement phosphorylate Crk/CrkL proteins, and that both Abl and Crk family proteins are required for adherens junction integrity in a pathway upstream of Rac. We and others have shown that Crk phosphorylation on the Abl-specific site is required for Rac activation and membrane localization (Fig. 5E) (15, 28) . The mechanism by which Crk phosphorylation by Abl results in Rac activation may involve the recruitment of the Crk-binding protein DOCK180, a guanine nucleotide exchange factor (GEF) for Rac (37) . Alternatively, Abl may activate Rac by phosphorylating Sos-1, which was reported to stimulate the Rac-GEF activity of Sos-1 (14) .
Abl kinases are required for both activation of Rac and inhibition of Rho at adherens junctions, and it is possible that these events may be coordinately linked. Abl may down-regulate Rho signaling indirectly by activating a Rac-ROS pathway (38) or directly by regulating the activities of a RhoGAP or RhoGEF. In this regard, activated RacV12 was reported to inhibit Rho by p190 RhoGAP (38) , and p190 RhoGAP was shown to be phosphorylated in an Arg-dependent manner in response to integrin engagement in neuronal cells (10) . However, we have not detected any changes in p190 RhoGAP tyrosine phosphorylation in the absence of Abl/Arg kinases or upon STI571 treatment in epithelial cells or fibroblasts (data not shown). Moreover, in agreement with published data (39), we found that p190 RhoGAP does not localize to adherens junctions in the cells analyzed here (data not shown). Thus, our data suggest that Abl substrates other than p190 RhoGAP are likely to regulate adherens junction formation and maintenance.
Together our findings implicate the Abl family of tyrosine kinases as regulators of intercellular adhesion in epithelial cells and fibroblasts and support the model depicted in SI Fig. 11 . These data and our previous results demonstrating that Abl kinases are required for the formation of the NMJ suggest that Abl kinases may function to modulate adhesive interactions between the same or different cell types. Changes in the activation of the Abl kinases also may modulate cell-cell adhesion during tumor progression and metastasis. In this regard, enhanced expression of Abl or Arg has been reported in a subset of metastatic colon carcinomas, pancreatic ductal carcinoma, and renal medullary carcinoma (40) (41) (42) . Excessive Abl/Arg kinase activity may disturb the proper balance of Rho and Rac activation and induce altered cytoskeletal reorganization, thereby affecting cell-cell adhesion.
Materials and Methods
Antibodies and Reagents. The following antibodies and chemical reagents were used: N-cadherin, ␤-tubulin, and actin (SigmaAldrich, St. Louis, MO); pCrkL Y207, pCrk Y221, and pMLC polyclonal (Cell Signaling Technology, Danvers, MA); E-cadherin, ␤-catenin, p120 catenin, and Crk (BD Biosciences Transduction Laboratories, Lexington, KY); ␣-catenin (Zymed Laboratories, South San Francisco, CA); Abl K12 and CrkL (Santa Cruz Biotechnology); Abl 8E9 (BD Biosciences PharMingen, San Diego, CA); Rac and Rho (Pierce Chemical, Rockford, IL); GFP (Roche Diagnostics, Indianapolis, IN); CY3-donkey anti-mouse, CY3-donkey anti-rabbit, and CY2-donkey anti-mouse (Jackson ImmunoResearch Laboratories, West Grove, PA); Alexa488-conjugated phalloidin, protein A-Sepharose, protein G-Sepharose, HRPlinked protein A, and ECL Western blotting reagents (Amersham Biosciences, Piscataway, NJ); HRP-linked goat anti-mouse IgG (Santa Cruz Biotechnology); HRP-linked goat anti-rabbit IgG and DAPI (Molecular Probes, Eugene, OR); and Y27632 (Calbiochem, San Diego, CA). Antibody to Arg was produced by immunizing rabbits with a peptide specific for a unique C-terminal region (9) . STI571 was a gift from B. Druker (Oregon Health Sciences University, Portland, OR). The pK1 Arg GFP plasmid was obtained from A. Koleske (Yale University, New Haven, CT). pK1 ArgPP (25) and MigR1 CrkYF (15) plasmids were generated as described. 
